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cryoimagingDystrophin, the main component of the dystrophin–glycoprotein complex, plays an important role in maintain-
ing the structural integrity of cells. It is also involved in the formation of the blood–brain barrier (BBB). To eluci-
date the impact of dystrophin disruption in vivo, we characterized changes in cerebral perfusion and diffusion in
dystrophin-deﬁcient mice (mdx) by magnetic resonance imaging (MRI). Arterial spin labeling (ASL) and
diffusion-weighted MRI (DWI) studies were performed on 2-month-old and 10-month-old mdx mice and
their age-matched wild-type controls (WT). The imaging results were correlated with Evan's blue extravasation
and vascular density studies. The results show that dystrophin disruption signiﬁcantly decreased themean cere-
bral diffusivity in both 2-month-old (7.38 ± 0.30 × 10-4 mm2/s) and 10-month-old (6.93 ± 0.53 × 10-4 mm2/s)
mdxmice as compared toWT(8.49±0.24×10-4, 8.24±0.25×10-4mm2/s, respectively). Therewas also an18%
decrease in cerebral perfusion in 10-month-old mdx mice as compared to WT, which was associated with en-
hanced arteriogenesis. The reduction in water diffusivity in mdx mice is likely due to an increase in cerebral
edema or the existence of large molecules in the extracellular space from a leaky BBB. The observation of
decreased perfusion in the setting of enhanced arteriogenesis may be caused by an increase of intracranial
pressure from cerebral edema. This study demonstrates the defects inwater handling at the BBB and consequent-
ly, abnormal perfusion associated with the absence of dystrophin.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The blood–brain barrier (BBB) ensures the proper physical andmet-
abolic environment for brain function. Endothelial cells lining the vascu-
lature of the brain are joined by tight junctions in order to prevent freeBB, blood–brain barrier; DGC,
ular dystrophy; IQ, intelligence
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. This is an open access article underdiffusion of large and hydrophilic molecules, including water, from the
blood into the brain parenchyma (Brightman and Reese, 1969; Reese
and Karnovsky, 1967). A major role of the tight junctions is to maintain
the physiologic and biochemical environment necessary for neuronal
ﬁring. The cytoskeleton is crucial in forming, anchoring, and maintain-
ing the BBB (Zlokovic, 2008). Disruption of the BBB leads to increased
permeability of large molecules, such as albumin, into the CNS, causing
neuronal dysfunction, edema, and a lower seizure threshold (Abbott
et al., 2006; Hawkins and Davis, 2005; Tomkins et al., 2008; van Vliet
et al., 2007).
Dystrophin, a major actin-binding component of the dystrophin gly-
coprotein complex (DGC), links cytoskeletal andmembrane elements in
the muscle (Tinsley et al., 1994) and brain (Lidov et al., 1990, 1993).
Inherited deﬁciency of functional dystrophin leads to Duchennemuscu-
lar dystrophy (DMD), an X-linked recessive disease leading to progres-
sive muscle degeneration. In addition to voluntary muscle weakness,
DMD patients suffer from ventilatory and cardiovascular failure at the
end stages of the disease. Functional dystrophin is also not expressed
in the brains of DMD patients (Hoffman et al., 1987). However, asidethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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gence quotient (IQ) assessments than that of healthy control children
(Cotton et al., 2001; Karagan, 1979), few studies have characterized
the structural and functional impact of dystrophin disruption in the
brain.
The dystrophin-nullmdxmouse has been used as a mouse model of
muscular dystrophy for over two decades (Sicinski et al., 1989). Aside
from the muscular phenotype, cognitive defects have also been ob-
served in mdxmice (Vaillend et al., 1995). The tight junction proteins
of the BBB were shown to be reduced and dysfunctional in the mdx
mouse brain, leading to a leaky BBB (Nico et al., 2003). Moreover, en-
hanced expression of matrix-metalloproteinase (MMP)-2 and -9 in
mdxmouse brainswas associatedwith increased expression of vascular
endothelial growth factor (VEGF; Nico et al., 2006). These in vitro obser-
vations provide the evidence of altered brain structure associated with
dystrophin deletion. A full understanding of the role of dystrophin in
maintaining the BBB and vascularization has yet to be studied in vivo
withmodern imaging technologieswhichwill likely support future clin-
ical investigations.
Arterial spin labeling (ASL) is a non-contrast MRI method that has
made signiﬁcant contributions towards assessing tissue perfusion
in vivo (Detre et al., 1992; Williams et al., 1992; Edelman et al., 1994;
Kwong et al., 1995; Kim and Tsekos, 1997; Wong et al., 1997; Pell
et al., 1999; Thomas, 2005). In ASL-MRI, water molecules are “magnet-
ically tagged” in the blood, leading to altered tissue longitudinalmagne-
tization that is proportional to tissue perfusion. This method does not
require exogenous paramagnetic contrast agents as in conventional Dy-
namic Contrast Enhanced (DCE) MRI perfusion techniques. Hence, ASL-
MRI may eventually become the preferred method for longitudinal im-
aging studies. In spite of its utility, ASL-MRI has yet to be fully applied to
understanding the pathophysiologic consequence of dystrophin disrup-
tion with regard to water movement and perfusion in the brain.
Diffusion-weighted MRI (DWI) has been invaluable in deﬁning
neurological disorders, particularly in the diagnosis of stroke and the
assessment of therapeutic interventions (Le Bihan et al., 1986; Kloska
et al., 2010; Schellinger et al., 2003; Sevick et al., 1990; Warach et al.,
1995). The signal intensity of a DW image reﬂects the restrictions on
Brownian motion of water molecules in the tissue, and the calculated
apparent diffusion coefﬁcient (ADC) provides a means to quantify
this diffusion under physiologic and pathologic states. HighADC values
are characteristic of tissue with relatively free water diffusion, e.g., in
extracellular space, as opposed to tissue water with a restricted
environment, e.g., in intracellular space (Le Bihan, 2007). Therefore,
the diffusion of water molecules as detected by DWI can be used to
delineate the neural structure, anatomy, and pathophysiology in the
absence of dystrophin.
The goal of this study was to characterize the impact of dystrophin
deletion on physiological and structural changes in the brain using
both in vivo and in vitromethods. Cerebral perfusion and brain structure
were evaluated by ASL and DWI, respectively. These in vivo imaging re-
sultswere comparedwith in vitro and ex vivo studies of vascular density.
The present study demonstrates the defects in perfusion and diffusion
associatedwith dystrophin disruption inmdxmice that can be observed
in vivo with MRI and the association of these in vivo imaging assess-
ments with histopathologic measures.Methods
Animal models
Studies were performed on young (2months old, n=10) and adult
(10 months old, n = 10) male dystrophin-null (mdx) and wild-type
(WT) mice of the C57/BL6 strain. All mice were obtained from Jackson
Laboratories (Bar Harbor, ME). All procedures involving animal care
and handling were performed according to institutional guidelines setforth by the Animal Care and Use Committee at Case Western Reserve
University.
Perfusion and diffusion MRI
Imaging studies were performed on a 7 T Bruker Biospec (Billerica,
MA) horizontal bore MRI scanner. Anesthesia was induced with 2%
isoﬂurane with supplemented O2 in an isoﬂurane induction chamber
and maintained via nosecone with 1.5% isoﬂurane once the animal
wasput in themagnet. The body temperaturewasmonitored andmain-
tained at approximately 36 °C by blowing hot air into the magnet
through a feedback control system. Respiratory gating and monitoring
was performed through an MR-compatible small animal gating and
monitoring system (SA Instruments, Stony Brook, NY) to reducemotion
artifacts during image acquisition.
Single-slice axial ASL brain images were acquired with a ﬂow-
sensitive alternating inversion recovery (FAIR) preparation sequence
followed by a centrically encoded fast imaging in steady precession
(FISP) imaging readout (Gao, et al., 2014). Speciﬁcally, arterial spin la-
beling was accomplished by respiratory-triggered, slice-selective
(4.5 mm thickness) and non-selective (global) inversion of magnetiza-
tion, respectively. The inversion pulse used a hyperbolic secant
adiabatic inversion pulse with a duration of 3 ms, and the inversion
thickness was set to three times that of the excitation pulse to ensure
a uniform inversion over the entire imaging slice. An inversion efﬁcien-
cy value of 1 was assumed. The FISP acquisition (including 10 dummy
scans) was implemented at 1420 ms following the inversion pulse.
This delay time allowed data acquisition to occur during the mid- to
late-stage of the subsequent breathing cycle. It is a balance between
maximizing blood ﬂow sensitivity and minimizing respiratory
motion artifacts. Imaging parameters are: ﬂip angle, 60°; TR, 2.4 ms;
TE, 1.2 ms; number of averages, 40; matrix size, 128 × 128; FOV, 30
× 30 mm2; slice thickness, 1.5 mm. A proton density image (M0) with
no inversion pulse was also acquired using the same imaging
parameters. A voxel-wise T1 map with the same spatial resolution was
also acquired with a FISP-based Look-Locker acquisition consisting of a
non-selective adiabatic inversion pulse followed by 10 continuous FISP
acquisitions with the following parameters: ﬂip angle, 10°; TR, 4.0 ms;
TE, 2.0 ms; number of averages, 40. Image reconstruction and analysis
were performed ofﬂine using custom-built software written in
MATLAB (MathWorks, Natick, MA). Perfusion maps were generated
from the magnetization difference of slice-selective and non-selective
inversion images (ΔM), proton density image (M0), and the T1 maps
(Gao, et al., 2014). A blood/tissue partition coefﬁcient (λ) of 0.9 mL/g
was used in this study (Herscovitch and Raichle, 1985).
Single-slice axial diffusion-weighted images (DWI) were acquired
with a diffusion-weighted echo-planar imaging (DW-EPI) acquisition.
Diffusion weighting was accomplished with two 4-ms (δ) diffusion-
encoding gradients separated by 15 ms (Δ), yielding a b value of
500 s/mm2 applied in the readout direction. The DW-EPI images
were acquired with the following parameters: TR, 5000; number of
averages, 5; matrix, 128 × 128; FOV, 30 × 30 mm2; slice thickness,
1 mm. Images were reconstructed and analyzed using custom-built
software written in MATLAB (MathWorks, Natick, MA). Voxel-wise
apparent diffusion coefﬁcient (ADC) maps were calculated by the
established equation: ADC = ln(I0/I)/b, where I0 and I are the signal
intensity of the b = 0 s/mm2 and the b = 500 s/mm2 images,
respectively.
Analysis of vascular density by immunocytochemistry
WT (2mo, n=4; 10 mo, n=5) andmdx (2mo, n=4; 10mo, n=
5) mice were deeply anesthetized with isoﬂurane after imaging. The
brains were excised and ﬁxed in 4% paraformaldehyde for 24 h at
4 °C. The tissue was transferred to 5% sucrose in PBS for 1 h followed
by 20% sucrose overnight at 4 °C. Subsequently, the brains were rapidly
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with liquid nitrogen. Tissues were sectioned at 10 μm slice thickness
at the location corresponding to the MR imaging slice. A total of 7 sec-
tions were obtained from each brain. Indirect immunoﬂuorescence
against CD31 (PECAM-1, 1:100; Sigma Aldrich, St. Louis, MO) was per-
formed to assess cerebral vascular density. DAPI (4′,6-diamidino-2-
phenylindole dihydrochloride; Sigma Aldrich, St. Louis, MO) staining
was used for nuclear identiﬁcation. Stained tissue sections were
photographed for the DAPI (blue) and PECAM-1 (red) channels. The
number of PECAM-1-positive cells per ﬁeld was quantiﬁed. All images
were photographed at the same exposure times and magniﬁcation.
The obtained values from all animals were averaged, and the results
were expressed as the mean number of PECAM-1-positive cells per
ﬁeld ± SD.
Analysis of BBB leakage using Evans blue staining
WT (2months old, n=2; 10months old, n=2) andmdx (2months
old, n= 2; 10 months old, n= 2) mice were injected intraperitoneally
with a bolus of 0.1 mL/10 g Evans blue (10 mg/mL; Sigma Aldrich, St.
Louis, MO). After 24 hours, the mice were deeply anesthetized with
isoﬂurane and the brains were excised and rapidly frozen in OCT
media (Electron Microscopy Sciences, Hatﬁeld, PA). Tissues were sec-
tioned at 10 μm slice thickness at the location corresponding to the
MR imaging slice. Evans blue extravasation was evaluated by ﬂuores-
cence in WT versus mdx.
Analysis of vascular density by cryoimaging
The remaining WT (2 months old, n = 2; 10 months old, n = 2)
and mdx (2 months old, n=2, 10 months old, n=2)mice were anes-
thetized with isoﬂurane and ﬂuorescein isothiocyanate-dextran (FITC-
dextran, 10 mg/mL; Sigma Aldrich, St. Louis, MO) was injected intrave-
nously at a dose of 200 mg/kg. After 10 minutes, the brains were
excised and rapidly frozen with liquid nitrogen in OCT media (Electron
Microscopy Sciences, Hatﬁeld, PA) and mounted to the cryoimaging
system. The tissue was sectioned in 25 μm slices and the bright-ﬁeld
and ﬂuorescent images from the cryoimaging system were processed
and analyzed with custom-built MATLAB (Mathworks Inc., Natick,
MA) and AMIRA (Mercury Computer Systems, San Diego, CA) softwareFig. 1. a–d. Representative diffusion images of 2-month-oldWT (a), 2-month-oldmdx (b), 10-m
fusion in C57/BL6WT (black) andmdx (white), respectively. Therewas a signiﬁcant decrease in
mice (*p b 0.0005). There was also a signiﬁcant age-dependent decrease in diffusion in young
Color bar is uniform in each panel.(Roy et al., 2009). The brain contour was traced manually from
the bright-ﬁeld images, and a mask was generated. The mask was ap-
plied to ﬂuorescent images, and the 3D cerebral vasculature was recon-
structed using thresholding and volume rendering methods (Qutaish
et al., 2012). The resolution for the reconstructed 3D images were 10.5
× 10.5 × 25 μm3.
Statistical analysis
All data are reported asmean±SD. A two-tailed, unpaired Student's
t-test was performed to compare mdx and WT mice. Statistical signiﬁ-
cance was established at a level of p b 0.05.
Results
Decreased cerebral diffusivity with dystrophin disruption
Representative brain apparent diffusion coefﬁcient (ADC) maps of
2- and 10-month-old mdx and WT mice are shown in Figs. 1a–d.
The mean and standard deviation for each group of mice are shown
in Fig. 1e. Mean diffusivity in 2-month-old mdx mice was 7.38 ±
0.30 × 10-4 mm2/s, which was signiﬁcantly lower than that in age-
matched WT mice (8.49 ± 0.24 × 10-4 mm2/s; Fig. 1e; p b 0.0005).
Furthermore, 10-month-oldmdxmice also exhibited a decrease in ce-
rebral mean diffusivity as compared to the age-matched WT mice
(6.93 ± 0.53 × 10-4 versus 8.24 ± 0.25 × 10-4 mm2/s; p b 0.0005).
In addition, a 2-tailed Student's t-test showed a signiﬁcant age-
related decrease in the mean ADC values of both the WT and mdx
mice (p b 0.05).
Abnormalities in cerebral perfusion in aged mdx mice
Representative cerebral perfusionmaps for the 2- and 10-month-old
mdx and WT mice are shown in Figs. 2a–d. The mean and standard
deviation for each group are shown in Fig. 2e. There was a 15% decrease
in cerebral perfusion in 10-month-old mdx mice as compared to
WT (Fig. 2e; p = 0.001), without any signiﬁcant difference in mean
cerebral T1 orM0 values (p= N.S.). The mean brain perfusion values for
the 2-month-old mdx mice were slightly lower than for 2-month-oldonth-oldWT (c), and 10-month-oldmdx (d). e. Mean cerebral (excluding ventricles) dif-
mean diffusion as compared toWT observed in themdx in both the 2- and 10-month-old
versus agedWT and mdx mice, respectively (#p b 0.05). Data represented as mean ± SD.
Fig. 2. a–d. Representative perfusion images of 2-month-oldWT (a), 2-month-oldmdx (b), 10-month-oldWT (c), and 10-month-oldmdx (d). e–h. Representative T1maps of 2-month-old
WT (e), 2-month-old mdx (f), 10-month-oldWT (g), and 10-month-oldmdx (h). i. Mean cerebral (excluding ventricles) perfusion from the ASL-FISPmethod in C57/BL6WT (black) and
mdx (white), respectively. There was a signiﬁcant decrease in mean perfusion as compared to aged WT observed in the aged mdx mice (p b 0.005). There was no signiﬁcant change in
perfusion in young versus agedWT (p N 0.3) or young versus aged mdx (p N 0.3), respectively. Data represented as mean ± SD. Color bar is uniform in each panel.
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observed.Disruption of blood–brain barrier integrity in mdx mice
To investigate the integrity of the BBB in the absence of dystrophin,
we examined the extravasation of Evans blue from blood vessels
histologically. There was a signiﬁcant leakage of Evans blue into the
cerebrum of both 2- and 10-month-old mdx mice as demonstrated in
Figs. 3a,c. There were few vessels demonstrating Evans blue extravasa-
tion in both young (2months old) and aged (10months old)WTmouse
brains (Figs. 3b,d).Enhanced cerebral arteriogenesis in aged mdx mice
Representative PECAM-1-stained immunoﬂuorescent images for
the 2- and 10-month-old mdx and WT mice are shown in Figs. 4a–d.
There was no difference in the amount of cerebral vasculature
(number of PECAM-1-positive cells) between the young mdx and WT
mice (Fig. 4e). Interestingly, there was enhanced arteriogenesis in
the aged (10 months old) mdx mice as compared to the controls, as
demonstrated by a 13% increase in PECAM-1-positive cells (Fig. 4e;
p b 0.05). Representative 3D vessel reconstructions from the FITC-
dextran cryoimaging are shown in Fig. 5 (see also Supplemental
Videos). Qualitatively, there were more vessels visible in the 2- and
10-month-old mdx mouse brains as compared to WT.Discussion
In this study, we report the ﬁrst in vivo evaluation of age-
dependent alterations in cerebral perfusion and diffusion in mdx
mice. In addition to BBB disruption, we have observed increased
arteriogenesis in the cerebrum as a result of dystrophin deletion.
Traditional Evans blue extravasation conﬁrmed an interruption at
the BBB in both the 2- and 10-month-old mdx mice. In addition,
in vivo DWI experiments established an alteration of the normal
cerebral microstructural and physiologic environment in both 2-
and 10-month-old mdx mice. Interestingly, decreased in vivo
perfusion was also present in the 10-month-old mdx mice despite
increased arteriogenesis observed in both cryoimaging and
immunocytochemistry.
Consistentwith the ﬁndings by immunocytochemistry, cryoimaging
demonstrates extensive arteriogenesis in mdx throughout the entire
brain as compared to WT. Previously, enhanced arteriogenesis was
observed in the hindlimbs of mdx mice (Straino et al., 2004). It was
also shown that deletion of dystrophin results in enhanced expression
of matrix-metalloproteinase (MMP)-2 and -9, which ultimately leads
to an increase of VEGF and VEGFR2 expression (Nico et al., 2006). In
addition to angiogenesis, increased VEGF activity may also contribute
towards an opening of tight junctions at the BBB and enhanced vascular
permeability (Schoch et al., 2002; Zhang et al., 2002). The observed
increase in arteriogenesis by both cryoimaging and immunocytochem-
istry in the current study is consistent with the observations of
enhanced VEGF activity in vitro (Nico et al., 2002). However, unlike
the qualitative results from cryoimaging, we did not see a difference
Fig. 3. a–d. Representative images of Evan's blue ﬂuorescence on axial sections of frozen 2-month-old mdx (a), 2-month-old WT (b), 10-month-old mdx (c), and 10-month-old WT
(d). Note the extravasation of Evan's blue (arrows) in the mdx mice.
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high-resolution, but limited sampling of the immunoﬂuorescence ex-
perimentsmay better reﬂect themolecular content of the tissue,where-
as the 3D cryoimaging data are more representative of the global
macrovascular structure. As such, the global nature of cryoimaging as
described herein provides unique and complementary information for
these types of investigation.
The decreased cerebral ADC observed in the current study likely
represents cellular edema as a result of BBB disruption. BBB disruption
in mdx mice due to reduced expression of tight junction proteins hasFig. 4. a–d. Representative images of indirect immunoﬂuorescence against CD31 (platelet end
frozen 2-month-old WT (a), 2-month-old mdx (b), 10-month-old WT (c), and 10-month-old
WT mice. Data are represented as mean ± SD. *p b 0.05 versus WT.been reported previously (Nico et al., 2003). Consequently, the osmotic
inﬂux of water into the cell causes cellular edema and a decrease in
extracellular space, leading to a decrease in ADC (Kucharczyk et al.,
1991; Moseley et al., 1990). While it has been shown that aqp4
facilitates the clearance of vasogenic edema as a result of BBB disrup-
tion (Papadopoulos et al., 2004), the lack of properly functioning
aqp4 channels at the BBB in mdx mice (Adams et al., 2008; Frigeri
et al., 2001) may prevent the removal of water from the cerebrum
and therefore worsen cellular edema. Alternatively, a leaky BBB may
also lead to an increase of large molecules in the extracellular spaceothelial cell adhesion molecule 1, PECAM-1) on axial sections of paraformaldehyde-ﬁxed
mdx (d). e. Quantiﬁcation of PECAM-1-positive cells in 2- and 10-month-old mdx and
Fig. 5. a–l. Representative dorsal (top row), lateral (middle row), and (bottom row) views of the 3D vessel reconstructions from 2-month-oldWT (a–c), 2-month-old mdx (d–f),
10-month-old WT (g–i), and 10-month-old mdx (j–l).
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space. Therefore, the observed ADC decrease in mdx brains may be the
result of cellular edema, increased extracellular protein content, en-
hanced vascular permeability, or a combination of these possible
mechanisms. The age-dependent reduction of ADC in 10-month-old
WT as compared to 2-month-old mice is supported by prior studies,
which describe decreasing ADC with age likely due to cellular atrophy
and an increase in cerebrospinal ﬂuid (CSF) compartments (Heiland
et al., 2002).
To the best of our knowledge, this is the ﬁrst study that demonstrat-
ed decreased perfusion in the setting of increased angiogenesis and a
chronically leaky BBB in themdx brain in vivo. This decrease in cerebral
perfusion is likely the result of cerebral edema, as observed by DWI. It
has been established that the presence of cerebral edema and/or
angiogenesis in the ﬁxed volume of the skull leads to an increase in
intracranial pressure (ICP; Adams and Ropper, 1997; Mokri, 2001).
Increased ICP in this way could decrease cerebral perfusion pressure
(CPP), which is the difference between mean arterial pressure and
ICP. The control of CPP ensures proper brain function, as a decrease in
CPP may lead to ischemia and an increase may contribute towards
raising the ICP (Powers, 1991; Schumann et al., 1998). As a result of
increased ICP, the consequent decrease of CPP ultimately leads to an
autoregulatory decrease in cerebral blood ﬂow. This decrease in perfu-
sion in mdx mice may compromise their ability to react to periods of
hypoxia.
There are several limitations in this initial study aimed at investi-
gating whether there were overall changes in diffusion and perfusion
in the brain of mdx mice that can be detected by MRI. First, fast imag-
ing sequences were used for both DWI and ASL acquisitions. The voxel
size and slice thicknesses used gave rise to partial volume averaging
that obscured the small white matter tracts in a mouse brain in vivo.
Future studies aimed at white/gray matter differentiation/evaluation
will require optimization of the imaging parameters or potentially
using a different imaging readout approach. Second, instead of
performing a comprehensive diffusion tensor imaging study, we per-
formed DWI in order not to overtly extend the acquisition time.
While DWI is sensitive to structural changes at the cellular level
(e.g., edema), a future diffusion tensor studywill be helpful to validate
and reﬁne our current ﬁndings.
Third, measurement of cerebral perfusion used a single inversion
time (TI) and the classic model that assumes equal T1 for blood andtissue (Detre et al., 1992; Kwong et al., 1995; Kim and Tsekos, 1997).
Furthermore, transit time is not considered in the calculation. A more
recent model by Pell et al. incorporated both the transit time (δ) and
the T1 of the blood (T1a) and the tissue (T1app) separately (Pell et al.,
1999). While the method requires the quantiﬁcation of both T1app and
T1a by using multiple inversion times, it allows more comprehensive
assessment of several physiological parameters that can impact blood
ﬂow. In calculating the cerebral blood ﬂow (CBF), the classic model
and the Pell model used the following equations respectively:
Classic : CBFC ¼
λ
2







 ΔM TIð Þ
M0
 FC T1; TIð Þ
Pell : CBFP ¼
λ
2
 ΔM TIð Þ
M0
 eδ=T1a  1=T1a−1=T1app
e− TI−δð Þ=T1app−e− TI−δð Þ=T1a
¼ λ
2
 ΔM TIð Þ
M0
 FP δ; T1a; T1app; TI
 
where FC and FP are the two terms in which the classic model and the
Pell model differ. These two terms are deﬁned as:
FC T1; TIð Þ ¼
eTI=T1
TI
FP δ; T1a; T1app; TI
 
¼ eδ=T1a  1=T1a−1=T1app
e− TI−δð Þ=T1app−e− TI−δð Þ=T1a







Hence, for a measured ΔM TIð ÞM0 , the ratio of measured blood ﬂow by
the two methods is
CBFC
CBFP
¼ FC T1; TIð Þ
FP δ; T1a; T1app; TI
 
Fig. 6. Comparison of the classicmodel and the Pellmodel. a and b. Simulated Fc and Fp, and CBFc/CBFP at 7 T, respectively. c and d. Simulated Fc and Fp, and CBFc/CBFP at 9.4 T, respectively.
Solid lines in a and c represent the classic model, while dotted lines represent the Pell model. Black, red, and blue represent tissue T1 of 1.4, 1.6, and 1.8 s, respectively.
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2.4 s at 7 T and 9.4 T, respectively (ex vivo measurement) (Dobre
et al., 2007), and a tissue T1 of 1.4, 1.6, and 1.8 s, respectively, the simu-
lated differences between the twomodels with CBF ranging from 100 to
400 mL/min/100 g are shown in Fig. 6. These results suggest that at a
ﬁeld strength of 7 T, the difference between the classic model and the
Pell model was b3% when tissue T1 was 1.8 s. However, the classic
model overestimated CBF by 12% to 16% when tissue T1 was 1.4 s
(Figs. 6a and b). In our current study, measured tissue T1 was ~1.7 s.
Hence, the calculated CBF difference should be within 8% compared to
the Pell model. At 9.4 T, there could be an up to 12% overestimation by
the classic model (Figs. 6c and d).
In summary, we have observed abnormal cerebral diffusivity,
enhanced angiogenesis, and decreased cerebral perfusion in the
mdx mouse. Our study is the ﬁrst to assess the consequence of dys-
trophin deletion on cerebral blood ﬂow in the mdx mouse model.
In vivo mouse studies are essential to further the translational value
of these results. Although this work is a step towards clinical transla-
tion, better mouse models of DMD need to be studied in further detail
since the mdx mouse has a mild phenotype in comparison to the
clinical presentation of DMD. The leaky BBB and decreased cerebral
perfusion observed in mdx mice may contribute towards the disrup-
tion of proper brain function observed in DMD patients. As the life
expectancy of DMD patients increases with improved therapies,
developing an understanding of the neurologic manifestations of
the dystrophin-null phenotype will lead to better patient manage-
ment when symptoms emerge. In particular, DMD patients suffering
from cardiac arrhythmias will be at an increased risk of stroke, and
thus understanding dystrophin's role at the BBB and response to
hypoxia is critical.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neuroimage.2014.08.053.
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